HK1258464A1 - 新的治療用途 - Google Patents
新的治療用途Info
- Publication number
- HK1258464A1 HK1258464A1 HK19100770.5A HK19100770A HK1258464A1 HK 1258464 A1 HK1258464 A1 HK 1258464A1 HK 19100770 A HK19100770 A HK 19100770A HK 1258464 A1 HK1258464 A1 HK 1258464A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- therapeutic uses
- new therapeutic
- new
- therapeutic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7125—Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7115—Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1700261.9A GB201700261D0 (en) | 2017-01-06 | 2017-01-06 | New therapeutic uses |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1258464A1 true HK1258464A1 (zh) | 2019-11-15 |
Family
ID=58463682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK19100770.5A HK1258464A1 (zh) | 2017-01-06 | 2019-01-16 | 新的治療用途 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20190388459A1 (zh) |
GB (2) | GB201700261D0 (zh) |
HK (1) | HK1258464A1 (zh) |
WO (1) | WO2018127587A1 (zh) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040033977A1 (en) * | 1990-08-14 | 2004-02-19 | Bennett C. Frank | Oligonucleotide modulation of cell adhesion |
US6096722A (en) * | 1990-08-14 | 2000-08-01 | Isis Pharmaceuticals Inc. | Antisense modulation of cell adhesion molecule expression and treatment of cell adhesion molecule-associated diseases |
AU7559894A (en) * | 1993-08-05 | 1995-02-28 | Isis Pharmaceuticals, Inc. | Oligomers for modulating metabolic function |
EP1115858B1 (de) * | 1998-09-25 | 2003-04-02 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Antisense-sequenzen für die hemmung der expression des adhäsionsmoleküls icam-1 |
EP1718274A2 (en) * | 2004-01-26 | 2006-11-08 | Control Delivery Systems, Inc. | Controlled and sustained delivery of nucleic acid-based therapeutic agents |
US20090275631A1 (en) * | 2004-12-02 | 2009-11-05 | Isis Pharmaceuticals, Inc. | Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease |
SG174581A1 (en) * | 2009-03-27 | 2011-10-28 | Merck Sharp & Dohme | RNA INTERFERENCE MEDIATED INHIBITION OF THE INTERCELLULAR ADHESION MOLECULE 1 (ICAM-1)GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
WO2013123996A1 (en) * | 2012-02-24 | 2013-08-29 | Astrazeneca Uk Limited | Novel sirna inhibitors of human icam-1 |
-
2017
- 2017-01-06 GB GBGB1700261.9A patent/GB201700261D0/en not_active Ceased
-
2018
- 2018-01-08 WO PCT/EP2018/050355 patent/WO2018127587A1/en active Application Filing
- 2018-01-08 US US16/476,223 patent/US20190388459A1/en not_active Abandoned
- 2018-01-08 GB GB1800257.6A patent/GB2558788B/en not_active Expired - Fee Related
-
2019
- 2019-01-16 HK HK19100770.5A patent/HK1258464A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US20190388459A1 (en) | 2019-12-26 |
GB201700261D0 (en) | 2017-02-22 |
WO2018127587A1 (en) | 2018-07-12 |
GB2558788A (en) | 2018-07-18 |
GB2558788B (en) | 2020-09-09 |
GB201800257D0 (en) | 2018-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201707153D0 (en) | Therapy | |
GB201719646D0 (en) | Therapy | |
GB201708663D0 (en) | Therapy | |
GB201608797D0 (en) | Therapeutic use | |
GB201707500D0 (en) | New therapy | |
GB201700526D0 (en) | Therapeutic use | |
GB2558788B (en) | New therapeutic uses | |
GB201715430D0 (en) | Therapy | |
GB201707945D0 (en) | Cnacer therapy | |
GB201707183D0 (en) | Macrophage-based therapy | |
GB201703453D0 (en) | Therapy | |
GB201703070D0 (en) | Therapy | |
GB201702601D0 (en) | Novel therapy | |
GB201706248D0 (en) | Combination therapy | |
GB201706242D0 (en) | Combination therapy | |
GB201706225D0 (en) | Combination therapy | |
GB201706234D0 (en) | Combination therapy | |
GB201706230D0 (en) | Combination therapy | |
GB201706231D0 (en) | Combination therapy | |
GB201706232D0 (en) | Combination therapy | |
GB201706249D0 (en) | Combination therapy | |
GB201706233D0 (en) | Combination therapy | |
GB201706247D0 (en) | Combination therapy | |
GB201706246D0 (en) | Combination therapy | |
GB201706245D0 (en) | Combination therapy |